HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
David I Marks Selected Research
David I Marks Research Topics
Disease
30
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2022 - 04/2003
21
Leukemia
01/2021 - 11/2004
20
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 02/2006
15
Graft vs Host Disease (Graft-Versus-Host Disease)
12/2021 - 11/2004
11
Neoplasms (Cancer)
04/2022 - 02/2011
9
Bronchiolitis Obliterans Syndrome
04/2022 - 10/2005
9
Philadelphia Chromosome
01/2021 - 05/2009
8
Multiple Myeloma
08/2017 - 12/2003
7
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
03/2022 - 03/2010
6
Lymphoma (Lymphomas)
12/2020 - 04/2003
6
Hematologic Neoplasms (Hematological Malignancy)
01/2019 - 06/2011
5
Multiple Sclerosis
05/2022 - 09/2015
5
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2020 - 10/2008
5
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2018 - 11/2009
4
Pathologic Complete Response
01/2020 - 02/2012
4
Infections
01/2019 - 10/2003
4
Aplastic Anemia (Anemia, Hypoplastic)
05/2016 - 02/2011
3
Chromosome Aberrations (Chromosome Abnormalities)
01/2022 - 01/2020
3
Non-Hodgkin Lymphoma (Lymphosarcoma)
07/2014 - 12/2008
3
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
05/2013 - 11/2003
2
Immunoglobulin Light-chain Amyloidosis
01/2021 - 08/2006
2
Primary Myelofibrosis (Myelosclerosis)
12/2020 - 03/2010
2
Rare Diseases (Rare Disease)
01/2020 - 11/2015
2
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2019 - 02/2006
2
Fever (Fevers)
01/2018 - 10/2003
2
Hodgkin Disease (Hodgkin's Disease)
01/2018 - 01/2009
2
Invasive Fungal Infections
02/2017 - 01/2017
2
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
04/2013 - 10/2010
2
Neutropenia
08/2012 - 10/2003
1
Amyloidosis
01/2021
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2020
1
monosomy Chromosome 7
01/2020
1
Seizures (Absence Seizure)
01/2019
1
Residual Neoplasm
01/2019
1
Histiocytic Sarcoma
01/2018
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell)
01/2018
1
Sickle Cell Anemia (Hemoglobin S Disease)
11/2017
1
Stroke (Strokes)
08/2017
1
Infertility (Sterility)
08/2017
1
Hypothyroidism
08/2017
1
Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
08/2017
1
Cataract (Cataracts)
08/2017
Drug/Important Bio-Agent (IBA)
8
Inotuzumab Ozogamicin
IBA
01/2021 - 08/2017
8
Alemtuzumab (Campath)
FDA Link
12/2020 - 06/2005
7
Cyclophosphamide (Cytoxan)
FDA Link
Generic
11/2022 - 04/2006
7
fludarabine
IBA
11/2021 - 06/2005
6
Busulfan (Busulfex)
FDA Link
11/2021 - 12/2013
5
Melphalan (Alkeran)
FDA Link
Generic
11/2021 - 06/2005
4
Cytarabine (Cytosar-U)
FDA Link
Generic
12/2020 - 02/2006
4
Antigens
IBA
01/2019 - 11/2004
3
Rituximab (Mabthera)
FDA Link
04/2022 - 11/2009
3
Antilymphocyte Serum (Anti-Thymocyte Globulin)
IBA
01/2020 - 06/2005
3
Steroids
IBA
01/2020 - 10/2018
3
Cyclosporine (Ciclosporin)
FDA Link
Generic
01/2019 - 10/2015
3
Methotrexate (Mexate)
FDA Link
Generic
01/2019 - 10/2015
3
Tacrolimus (Prograf)
FDA Link
Generic
01/2019 - 10/2015
3
Calcineurin Inhibitors
IBA
01/2019 - 01/2018
3
Voriconazole (Vfend)
FDA Link
Generic
01/2017 - 11/2011
3
Imatinib Mesylate (Gleevec)
FDA Link
02/2014 - 10/2008
3
HLA Antigens (Human Leukocyte Antigens)
IBA
12/2013 - 03/2009
2
Monoclonal Antibodies
IBA
04/2022 - 11/2009
2
Bortezomib (Velcade)
FDA Link
01/2021 - 02/2017
2
Etoposide (VP 16)
FDA Link
Generic
12/2020 - 04/2006
2
Calicheamicins
IBA
01/2019 - 01/2018
2
Mycophenolic Acid (Cellcept)
FDA Link
Generic
01/2019 - 01/2019
2
Mitoxantrone (Novantrone)
FDA Link
Generic
01/2018 - 08/2017
2
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
01/2018 - 08/2017
2
Azoles
IBA
02/2017 - 03/2015
2
Antifungal Agents
IBA
01/2017 - 05/2003
2
Itraconazole (Sporanox)
FDA Link
Generic
03/2015 - 11/2011
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
01/2022
1
tisagenlecleucel
IBA
12/2021
1
Carmustine (FIVB)
FDA Link
12/2020
1
nelarabine (506U78)
FDA Link
01/2020
1
remestemcel-l
IBA
01/2020
1
Anticonvulsants (Antiepileptic Drugs)
IBA
01/2019
1
HLA-A Antigens (HLA-A)
IBA
01/2019
1
2-aminoethylmethyl sulfone
IBA
01/2019
1
Untranslated Regions (Untranslated Region)
IBA
01/2019
1
Phenytoin (Dilantin)
FDA Link
Generic
01/2019
1
DNA (Deoxyribonucleic Acid)
IBA
11/2018
1
Perforin
IBA
11/2017
1
Hormones (Hormone)
IBA
08/2017
1
Growth Hormone (Somatotropin)
IBA
08/2017
1
Bilirubin
IBA
08/2017
1
Alkylating Agents
IBA
08/2017
Therapy/Procedure
49
Cell Transplantation
11/2022 - 02/2006
35
Transplantation
04/2022 - 04/2003
31
Therapeutics
04/2022 - 04/2008
20
Hematopoietic Stem Cell Transplantation
01/2021 - 11/2003
17
Stem Cell Transplantation
12/2021 - 10/2002
17
Homologous Transplantation
01/2019 - 02/2006
16
Drug Therapy (Chemotherapy)
10/2019 - 08/2006
9
Autologous Transplantation
02/2017 - 02/2006
5
Induction Chemotherapy
01/2021 - 03/2006
4
Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2018 - 04/2003
2
Intravenous Infusions
05/2022 - 09/2015
2
Donor Selection
03/2022 - 01/2019
2
Immunotherapy
12/2020 - 11/2014
2
Salvage Therapy
01/2020 - 08/2017